国资委:央企所属子企业中混合所有制企业户数占比超70%
国务院国有企业改革领导小组办公室副主任、国务院国资委副主任翁杰明表示,公司制改革完成以来,国药集团、南航集团、东航集团积极推动股权多元化改革,引入具有协同效应的战略投资者,实现股权结构不断优化。积极有序推进充分竞争行业和领域混改,有效探索电力、民航、电信、军工等重要领域混改,中央企业所属子企业中混合所有制企业户数占比超过70%,有力促进各种所有制资本取长补短、相互促进、共同发展。
翁杰明并表示,目前央企621户子企业已选聘职业经理人近5,000人,119户控股上市公司实施了股权激励,集团总部部门数量平均压缩超过17%,人员编制平均减少20%。(ta/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.